Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin’s Lymphoma
Study Information
Alliance Study ID: CALGB-50203
NCT Study ID (ClinicalTrials.gov): NCT00086801
Alliance Committee: Lymphoma
Disease or Cancer Type: Lymphoma
Alliance Study Chair: David Straus, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, vinblastine, and gemcitabine, work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating patients with newly diagnosed stage I or stage II Hodgkin’s lymphoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information